BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 15, 2026
Breaking News: Tracking hantavirus across the globe
Breaking News: Tracking hantavirus across the globe
Breaking News: Tracking hantavirus across the globe
Home
»
Topics
» BioWorld Science, Nephrology
BioWorld Science, Nephrology
RSS
Recordati and Almirall launch silodosin for treatment of BPH symptoms in Spain
Oct. 11, 2010
Keryx advances phase III program for hyperphosphatemia treatment Zerenex
Oct. 4, 2010
Walter Chilcott acquires U.S. rights to Enablex from Novartis
Sep. 28, 2010
Vifor and Kissei Pharma partner to develop and market PA-21 in Japan
Sep. 27, 2010
Abbott and Reata to codevelop bardoxolone methyl for CKD
Sep. 27, 2010
Relypsa completes financing round to support RLY-5016 development
Sep. 23, 2010
FibroGen receives Chinese approval to begin clinical trials of FG-4592 in CKD anemia
Sep. 22, 2010
AP-214 reduces development of acute kidney injury in phase II trial
Sep. 14, 2010
Studies evaluate tamsulosin and doxazosin for urolithiasis
Sep. 6, 2010
PEARL-HF study shows reduced hyperkalemia with RLY-5016
Sep. 1, 2010
Previous
1
2
…
126
127
128
129
130
131
132
133
134
…
328
329
Next